Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most ...

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study Multivariable regression ...

Burkitt lymphoma is a form of non-Hodgkin's lymphoma in which cancer starts in immune cells called B-cells. Recognized as a fast growing human tumor, Burkitt lymphoma is associated with impaired ...

Burkitt’s leukemia, or Burkitt’s lymphoma, occurs when tumor cells develop in the bone marrow and bloodstream. Burkitt’s lymphoma is a rare type of non-Hodgkin lymphoma. Lymphoma is a blood cancer ...

Burkitt's lymphoma is a highly aggressive blood cancer that primarily affects children and young adults. It is driven by a ...

A 72-year-old patient with Burkitt lymphoma was successfully treated with nivolumab after standard-of-care chemotherapy failed. A new case report is raising the possibility that nivolumab (Opdivo) may ...

Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma whose diagnosis relies on integrated clinical, pathological, and imaging assessments. Established diagnostic criteria include ...

Adult patients with a type of cancer known as Burkitt lymphoma had excellent long-term survival rates -- upwards of 90 percent -- following treatment with low-intensity chemotherapy regimens, ...

A study has found strong similarities between children with endemic Burkitt lymphoma — an aggressive cancer that attacks the body's defense system and children with silent malaria infection. Endemic ...

Burkitt lymphoma is an aggressive cancer that starts in B cells, which are part of the immune system. It can lead to death, but intensive treatment can improve the likelihood of long-term survival. In ...